SCHEMBL22984505

SCHEMBL22984505

CCCCC(C)(CCC)OCCCNC(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.53
▸ LMNA P02545 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ L3MBTL1 Q9Y468 3/20 0.52
▸ MAPT P10636 2/20 0.52
▸ TGM2 P21980 1/20 0.48
▸ KEAP1 Q14145 2/20 0.47
▸ NFE2L2 Q16236 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ FAAH O00519 1/20 0.43
▸ MBOAT4 Q96T53 1/20 0.43
▸ CTSL P07711 1/20 0.43
▸ CTSS P25774 1/20 0.43
▸ SIRT2 Q8IXJ6 1/20 0.42
▸ SIRT1 Q96EB6 1/20 0.42
▸ FOLH1 Q04609 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23605272 0.96 HTT (0.56) HTTLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL22984651 0.83 HTT (0.63) HTTLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL19606708 0.82 HTT (0.59) HTTLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL1667805 0.81 HTT (0.72) HTTLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL8290406 0.80 HTT (0.70) HTTLMNASMN1; SMN2L3MBTL1MAPT
Ammonia Solution, Strong SCHEMBL10743947 0.80 HTT (0.70) HTTLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL14288941 0.79 LMNA (0.69) HTTLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL3364812 0.79 HTT (0.68) HTTLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL11973884 0.79 HTT (0.68) HTTLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL10599151 0.79 HTT (0.68) HTTLMNASMN1; SMN2L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919910-B2 Seco macrolide compounds FIDELTA D.O.O. (HR) 2021-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919910-B2 Seco macrolide compounds SEC61B, SEC16A, SEC61A1 HTT 1822/4885LMNA 1215/4885SMN1; SMN2 2262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback